IDEAS home Printed from https://ideas.repec.org/a/bla/glopol/v12y2021is6p12-20.html
   My bibliography  Save this article

21st Century Capitalism and Innovation for Health

Author

Listed:
  • Susan K. Sell

Abstract

21st century capitalism undermines health outcomes in myriad ways. Structural economic changes have had negative effects on medical innovation and public health and are poorly aligned with social goals. Key features of the contemporary political economy include both monopoly capitalism, based upon stringent intellectual (IP) protection that suppresses economic competition, and Wall Street capitalism, or financialization, that prioritizes value extraction over value creation to maximize shareholder value. Contemporary trends in the pharmaceutical and medical device industries, digital health, and regulatory change demonstrate some of the negative impacts of 21st century capitalism on public health.

Suggested Citation

  • Susan K. Sell, 2021. "21st Century Capitalism and Innovation for Health," Global Policy, London School of Economics and Political Science, vol. 12(S6), pages 12-20, July.
    • Handle: RePEc:bla:glopol:v:12:y:2021:i:s6:p:12-20
    DOI: 10.1111/1758-5899.12911
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/1758-5899.12911
    Download Restriction: no
    File URL: https://libkey.io/10.1111/1758-5899.12911?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Schwartz, Herman Mark, 2017. "Club goods, intellectual property rights, and profitability in the information economy†," Business and Politics, Cambridge University Press, vol. 19(2), pages 191-214, June.
    2. Lehoux, P. & Daudelin, G. & Williams-Jones, B. & Denis, J.-L. & Longo, C., 2014. "How do business model and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs," Research Policy, Elsevier, vol. 43(6), pages 1025-1038.
    3. Mariana Mazzucato & Victor Roy, 2019. "Rethinking value in health innovation: from mystifications towards prescriptions," Journal of Economic Policy Reform, Taylor & Francis Journals, vol. 22(2), pages 101-119, April.
    4. P. Lehoux & F. A. Miller & G. Daudelin & D. R. Urbach, 2016. "How venture capitalists decide which new medical technologies come to exist," Science and Public Policy, Oxford University Press, vol. 43(3), pages 375-385.
    5. Sell,Susan K., 2003. "Private Power, Public Law," Cambridge Books, Cambridge University Press, number 9780521819145, January.
    6. Pascale Lehoux & Hudson Pacifico Silva & Renata Pozelli Sabio & Federico Roncarolo, 2018. "The Unexplored Contribution of Responsible Innovation in Health to Sustainable Development Goals," Sustainability, MDPI, vol. 10(11), pages 1-21, November.
    7. Ugo Pagano, 2014. "The crisis of intellectual monopoly capitalism," Cambridge Journal of Economics, Cambridge Political Economy Society, vol. 38(6), pages 1409-1429.
    8. Gleadle, Pauline & Parris, Stuart & Shipman, Alan & Simonetti, Roberto, 2014. "Restructuring and innovation in pharmaceuticals and biotechs: The impact of financialisation," CRITICAL PERSPECTIVES ON ACCOUNTING, Elsevier, vol. 25(1), pages 67-77.
    9. Öner Tulum & William Lazonick, 2018. "Financialized Corporations in a National Innovation System: The U.S. Pharmaceutical Industry," International Journal of Political Economy, Taylor & Francis Journals, vol. 47(3-4), pages 281-316, October.
    10. Mariana Mazzucato & Victor Roy, 2019. "Rethinking value in health innovation: from mystifications towards prescriptions," Journal of Economic Policy Reform, Taylor and Francis Journals, vol. 22(2), pages 101-119, April.
    11. Sell,Susan K., 2003. "Private Power, Public Law," Cambridge Books, Cambridge University Press, number 9780521525398, January.
    12. Benjamin M. Hunter & Susan F. Murray, 2019. "Deconstructing the Financialization of Healthcare," Development and Change, International Institute of Social Studies, vol. 50(5), pages 1263-1287, September.
    13. Lehoux, P. & Miller, F.A. & Daudelin, G., 2017. "Converting clinical risks into economic value: The role of expectations and institutions in health technology development," Technological Forecasting and Social Change, Elsevier, vol. 117(C), pages 206-216.
    14. Busfield, Joan, 2020. "Documenting the financialisation of the pharmaceutical industry," Social Science & Medicine, Elsevier, vol. 258(C).
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Susan K. Sell, 2020. "What COVID-19 Reveals About Twenty-First Century Capitalism: Adversity and Opportunity," Development, Palgrave Macmillan;Society for International Deveopment, vol. 63(2), pages 150-156, December.
    2. Tristan Auvray & Cédric Durand & Joel Rabinovich & Cecilia Rikap, 2020. "Financialization's conservation and transformation: from Mark I to Mark II," Working Papers hal-03079425, HAL.
    3. repec:hal:cepnwp:hal-03079425 is not listed on IDEAS
    4. Tristan Auvray & Cédric Durand & Joel Rabinovich & Cecilia Rikap, 2021. "Corporate financialization’s conservation and transformation: from Mark I to Mark II," Review of Evolutionary Political Economy, Springer, vol. 2(3), pages 431-457, December.
    5. Bayer, Patrick & Marcoux, Christopher & Urpelainen, Johannes, 2013. "Leveraging private capital for climate mitigation: Evidence from the Clean Development Mechanism," Ecological Economics, Elsevier, vol. 96(C), pages 14-24.
    6. Emilie Cloatre & Robert Dingwall, 2013. "“Embedded regulation:” The migration of objects, scripts, and governance," Regulation & Governance, John Wiley & Sons, vol. 7(3), pages 365-386, September.
    7. Suma Athreye & Lucia Piscitello & Kenneth C. Shadlen, 2020. "Twenty-five years since TRIPS: Patent policy and international business," Journal of International Business Policy, Palgrave Macmillan, vol. 3(4), pages 315-328, December.
    8. Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
    9. Suzuki, Mao, 2020. "Profits before patients? Analyzing donors’ economic motives for foreign aid in the health sector," World Development, Elsevier, vol. 132(C).
    10. Haunss, Sebastian, 2013. "Enforcement vs. access: wrestling with intellectual property on the internet," Internet Policy Review: Journal on Internet Regulation, Alexander von Humboldt Institute for Internet and Society (HIIG), Berlin, vol. 2(2), pages 1-9.
    11. El-Bialy, Nora, 2010. "The role of institutions within the IPR enforcement: The case of de facto software protection in Egypt," Discussion Papers on Strategy and Innovation 10-02, Philipps-University Marburg, Department of Technology and Innovation Management (TIM).
    12. Leonhard Dobusch & Sigrid Quack, 2013. "Framing standards, mobilizing users: Copyright versus fair use in transnational regulation," Review of International Political Economy, Taylor & Francis Journals, vol. 20(1), pages 52-88, February.
    13. Jandhyala, Srividya, 2015. "International and domestic dynamics of intellectual property protection," Journal of World Business, Elsevier, vol. 50(2), pages 284-293.
    14. Dai, Rong & Watal, Jayashree, 2021. "Product patents and access to innovative medicines," Social Science & Medicine, Elsevier, vol. 291(C).
    15. Stephen, Matthew D. & Parízek, Michal, 2019. "New Powers and the Distribution of Preferences in Global Trade Governance: From Deadlock and Drift to Fragmentation," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 24(6), pages 735-758.
    16. Mohammad Abdulmahdi Amin Alfaouri, 2020. "THE IMPACT OF TRIPS ON IPRs PROTECTION IN JORDAN, AS A PRIME EXAMPLE OF A DEVELOPING COUNTRY," Oradea Journal of Business and Economics, University of Oradea, Faculty of Economics, vol. 5(special), pages 154-162, June.
    17. Olga Sezneva, 2013. "Re-thinking Copyright Through the Copy in Russia," Journal of Cultural Economy, Taylor & Francis Journals, vol. 6(4), pages 472-487, November.
    18. Donald W. Light, 2007. "Globalizing Restricted and Segmented Markets: Challenges to Theory and Values in Economic Sociology," The ANNALS of the American Academy of Political and Social Science, , vol. 610(1), pages 232-245, March.
    19. David Clayton, 2011. "Trade‐Offs And Rip‐Offs: Imitation‐Led Industrialisation And The Evolution Of Trademark Law In Hong Kong," Australian Economic History Review, Economic History Society of Australia and New Zealand, vol. 51(2), pages 178-198, July.
    20. Matthew David & Debora J. Halbert, 2017. "Intellectual Property & Global Policy," Global Policy, London School of Economics and Political Science, vol. 8(2), pages 149-158, May.
    21. Nitsan Chorev, 2013. "Restructuring neoliberalism at the World Health Organization," Review of International Political Economy, Taylor & Francis Journals, vol. 20(4), pages 627-666, August.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:glopol:v:12:y:2021:i:s6:p:12-20. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://edirc.repec.org/data/lsepsuk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.